Indivior Pharmaceuticals, Inc. (INDV)
36.00
+0.09
(+0.25%)
USD |
NASDAQ |
Sep 24, 16:00
36.00
0.00 (0.00%)
After-Hours: 19:59
Indivior Pharmaceuticals Gross Profit (Annual) : 1.016B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.016B |
| December 31, 2024 | 977.00M |
| December 31, 2023 | 919.00M |
| December 31, 2022 | 729.00M |
| December 31, 2021 | 651.00M |
| December 31, 2020 | 538.00M |
| December 31, 2019 | 626.00M |
| December 31, 2018 | 864.00M |
| Date | Value |
|---|---|
| December 31, 2017 | 976.00M |
| December 31, 2016 | 937.00M |
| December 31, 2015 | 885.00M |
| December 31, 2014 | 994.00M |
| December 31, 2013 | 1.084B |
| December 31, 2012 | 1.218B |
| December 31, 2011 | 1.148B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Supernus Pharmaceuticals, Inc. | 552.83M |
| Liquidia Corp. | 144.25M |
| Eli Lilly & Co. | 54.13B |
| Collegium Pharmaceutical, Inc. | 463.26M |
| Bristol Myers Squibb Co. | 31.76B |